U.S. Healthtech Stock News

Why Marvell Technology (MRVL) is Back on Investors’ Radar Marvell Technology (MRVL) has come back into focus after a sharp share price move over the past month, with the stock showing a return of about 62% alongside strong longer term total returns. See our latest analysis for Marvell Technology. That sharp 61.5% 30 day share price return and 83.3% 90 day share price return, alongside a 161.9% 1 year total shareholder return, suggest strong momentum even after the recent 3.1% 1 day pullback...

Wave Life Sciences (WVE) has opened Q1 2026 with revenue of US$38.2 million and a basic EPS loss of US$0.13, compared with Q1 2025 revenue of US$9.2 million and a basic EPS loss of US$0.29. Over the same stretch, trailing twelve month revenue moved from US$104.9 million in Q1 2025 to US$71.8 million in Q1 2026, while trailing EPS shifted from a loss of US$0.77 to a loss of US$1.03, creating a mixed read on top line scale versus ongoing earnings pressure. For investors, the key question is...

If you are wondering whether Moelis at US$69.69 is priced attractively or already baking in a lot of optimism, the starting point is to look closely at what the current valuation actually reflects. The stock has returned 1.4% over the last 7 days and 28.4% over the last 30 days, while the 1 year return sits at 36.3% and the 3 year and 5 year returns are 117.4% and 72.7% respectively, with a year to date return of a 2.1% decline. Recent price moves have been set against ongoing attention on...

American Tower (AMT) opened 2026 with Q1 results that included total revenue of US$2.7 billion, basic EPS of US$1.84 and net income of US$859.5 million. This comes in a year where earnings growth over the past 12 months has been negative and the net profit margin has moved from 31.9% to 23.8%. Over recent quarters the company has seen revenue hold around US$2.5 billion to US$2.7 billion, while basic EPS has ranged from US$0.78 to US$2.63. This gives a clear view of how current profitability...

Rithm Capital Q1 2026 results in focus Rithm Capital (RITM) opened 2026 with Q1 revenue of US$961.3 million and basic EPS of US$0.12, setting the tone for how the rest of the year might shape up for shareholders watching income and capital returns. The company has seen quarterly revenue move from US$693.3 million in Q1 2025 through US$1.25 billion in Q4 2024 to US$961.3 million most recently. EPS over that span ranged from US$0.07 in Q1 2025 to US$0.54 in Q2 2025 and now sits at US$0.12,...

Capital Bancorp (CBNK) opened Q1 2026 with total revenue of US$59.6 million and net income of US$12.0 million, translating to EPS of US$0.74. Trailing 12 month figures show revenue of US$233.2 million and net income of US$55.3 million alongside EPS of US$3.35. Over the past year, the company has reported revenue moving from US$170.7 million to US$233.2 million and EPS rising from US$2.12 to US$3.35. With net margin now framed by these higher earnings and solid loan growth, the latest quarter...

Curbline Properties (CURB) opened Q1 2026 with total revenue of US$58.0 million and basic EPS of US$0.03, setting the tone for how the year is starting to shape up. The company has seen quarterly revenue move from US$38.7 million in Q1 2025 to US$58.0 million in Q1 2026, while basic EPS shifted from US$0.10 to US$0.03 over the same stretch, giving you a clear view of how top line momentum compares with per share earnings. With trailing net profit margins running at 21.5% versus 8.3% in the...

Sysco (SYY) has just posted another set of quarterly numbers, with Q2 2026 revenue at US$20.8b, basic EPS of US$0.81 and net income of US$389m setting the tone for how investors assess the latest update. Over the past few reported periods, revenue has moved from US$20.2b and EPS of US$0.83 in Q2 2025 to US$21.1b and EPS of US$0.99 in Q1 2026, before settling at the most recent Q2 levels. This provides a clearer run-rate backdrop for the current release. With trailing net profit margins cited...

Polaris Q1 2026 earnings snapshot Polaris (PII) has opened 2026 with Q1 revenue of US$1,674.8 million and a basic EPS loss of US$0.83, as the company remains in the red on both the quarter and the trailing twelve months, where EPS sits at a loss of US$7.82 on revenue of US$7.4 billion. Over the last five reported quarters, revenue has moved between US$1,557.9 million and US$1,941.6 million, while quarterly basic EPS has ranged from a loss of US$0.28 to a loss of US$5.34. This frames the...

Five Star Bancorp (FSBC) opened 2026 with Q1 total revenue of US$42.4 million and basic EPS of US$0.88, supported by net income of US$18.6 million. The company has seen revenue move from US$33.9 million and EPS of US$0.63 in Q4 2024 to US$40.7 million and EPS of US$0.83 in Q4 2025. This sets up Q1 2026 against a backdrop of rising top line and per share earnings over recent periods. For investors, that combination of revenue growth and expanding earnings is closely linked to the margin story...

Ecolab (ECL) Q1 2026 earnings snapshot Ecolab (ECL) opened 2026 with Q1 revenue of US$4.1 billion and basic EPS of US$1.53, alongside trailing twelve month revenue of US$16.5 billion and EPS of US$7.44 that frame how the latest quarter fits into the broader run rate. Over the past year, the company has seen quarterly revenue move from US$3,695 million in Q1 2025 to US$4,066.1 million in Q1 2026, while basic EPS over that same period shifted from US$1.42 to US$1.53, giving investors a clear...

Parker-Hannifin (NYSE:PH) has approved an 11% increase in its quarterly dividend. The decision extends the company’s record to 70 consecutive years of annual dividend increases. This also marks 304 consecutive quarterly dividend payments to shareholders. Parker-Hannifin, trading at $962.26, is reinforcing its identity as an income-focused industrial name with this latest dividend move. The stock is up 8.3% over the past month, 7.6% year to date, and 61.1% over the past year, reflecting...

ANI Pharmaceuticals recently launched Pimozide Tablets 1 mg and 2 mg in the U.S., a generic version of Orap, entering a market with approximately US$3.10 million in annual sales based on February 2026 IQVIA data. Coming alongside the launch of Carbamazepine Extended Release Capsules, these additions expand ANI’s generic portfolio and could modestly broaden its revenue base in complex therapies. Next, we’ll examine how these new generic launches, particularly Pimozide’s entry into a niche...

If you are wondering whether Eaton's current share price fairly reflects its quality and prospects, it helps to break the story into what the market has done and what the fundamentals may justify. At a last close of US$413.07, Eaton has delivered returns of 0.8% over 7 days, 15.6% over 30 days, 26.2% year to date, 43.8% over 1 year, 148.5% over 3 years and 210.0% over 5 years, which gives useful context before looking at valuation. Recent coverage around Eaton has focused on its role in...

Burnham Holdings (OTCPK:BURC.A) has opened Q1 2026 reporting season on the back of a volatile 2025, capped by Q4 revenue of US$91.1 million and a basic EPS loss of US$6.66 as net income excluding extra items came in at a loss of US$31.3 million. Over recent quarters the company has seen revenue move from US$64.8 million in Q1 2025 to US$52.9 million in Q2, US$58.3 million in Q3 and US$91.1 million in Q4. EPS has swung from a profit of US$0.72 in Q1 to a loss of US$0.33 in Q2, then to a profit...

California BanCorp (BCAL) has just reported its Q1 2026 results, with the latest quarterly snapshot anchored by Q4 2025 revenue of US$50.3 million and basic EPS of US$0.51, supported by trailing 12 month net income of US$63.1 million and basic EPS of US$1.95. Over the past few quarters, the company has seen revenue move from US$49.4 million in Q4 2024 to US$50.3 million in Q4 2025, while quarterly basic EPS shifted from US$0.52 to US$0.51 over the same period, against a backdrop of trailing...

Hope Bancorp (HOPE) has just opened Q1 2026 earnings season with a recent run of quarterly results that show total revenue of US$105.6 million and basic EPS of US$0.20 in Q4 2024, moving to US$109.7 million of revenue and EPS of US$0.17 in Q1 2025, then US$77.1 million and a loss per share of US$0.22 in Q2 2025, before reaching US$130.1 million of revenue and EPS of US$0.24 in Q3 2025 and US$139.4 million with EPS of US$0.29 in Q4 2025. Over the same stretch, trailing twelve month figures...

If you are wondering whether GDS Holdings at around US$43.99 is offering value or stretching expectations, the recent share price path gives you a lot to think about. The stock has returned 1.2% over the past week, 8.9% over the last month, 14.7% year to date, 84.5% over 1 year and 218.8% over 3 years, while the 5 year return stands at a 42.2% decline. Recent coverage has focused on how GDS Holdings fits into investor interest around data infrastructure and related technology names, with...

Investors may be wondering whether Omnicell at around US$45.51 is offering real value right now, or if the recent excitement has already been priced in. The stock has moved sharply in the short term, with a 23.8% return over 7 days, 39.0% over 30 days, 0.8% year to date, and 44.9% over 1 year, while the 3 year and 5 year returns sit at 22.2% and 67.6% declines respectively. These swings have arrived alongside ongoing attention on medication management and hospital automation solutions. This...

Camden National (CAC) has put fresh numbers on the table for Q1 2026, coming off Q4 2025 revenue of US$65.1 million and basic EPS of US$1.34, backed by trailing 12 month revenue of US$233.5 million and EPS of US$3.86. Over recent quarters the company has seen revenue move from US$44.8 million in Q3 2024 to US$55.4 million in Q2 2025 and then to US$65.1 million in Q4 2025. Over the same period, quarterly EPS has shifted from US$0.90 to US$0.83 and then to US$1.25 before reaching US$1.34. This...

Bed Bath & Beyond (BBBY) opened Q1 2026 with revenue of US$247.8 million and a basic EPS loss of US$0.24, as investors weigh another quarter of negative earnings against the broader story around the business. The company reported quarterly revenue of US$231.7 million in Q1 2025 and US$247.8 million in Q1 2026, while basic EPS over that span has ranged from a loss of US$0.74 to a loss of US$0.24. This frames an earnings picture where the key question is how much longer margins remain...

CBRE Group (NYSE:CBRE) is forecasting a significant pickup in commercial real estate transaction volumes through 2026 to 2027. The company is highlighting rapid AI adoption across the sector as clients seek more efficient operations and better data transparency. CBRE is expanding its data center partnerships and infrastructure capabilities to support rising demand tied to digital and AI workloads. CBRE Group, a global commercial real estate services firm, is using its latest sector outlook...

Recent performance snapshot Dycom Industries (DY) has drawn fresh attention after recent share price moves, with the stock down 3% over the past day, nearly flat over the past week, and showing stronger gains over the past month and past 3 months. See our latest analysis for Dycom Industries. At a share price of $403.45, Dycom’s recent 18% 1 month share price return and 16% year to date gain sit alongside a very large 1 year total shareholder return. This suggests momentum has been building...

COPT Defense Properties (CDP) opened 2026 with Q1 revenue of US$200.6 million and basic EPS of US$0.34, setting a clear marker for its latest reporting season. The company reported revenue of US$188.2 million in Q1 2025 and US$200.6 million in Q1 2026, while basic EPS moved from US$0.31 to US$0.34 over the same period, giving investors a straightforward view of top line and per share trends into this quarter. With trailing net margins higher than a year ago and earnings growth running ahead...